Analysis of oral microbiota alterations induced by Helicobacter pylori infection and vonoprazan‐amoxicillin dual therapy for Helicobacter pylori eradication

The oral cavity is considered a potential reservoir of Helicobacter pylori (H. pylori), and the imbalance of oral microbiota directly reflects the health of the host. We aimed to explore the relationship among oral microbiota, H. pylori infection, and vonoprazan‐amoxicillin (VA) dual therapy for H. pylori eradication.

[1]  X. Shu,et al.  Altered Gut Microbiota and Short-Chain Fatty Acids After Vonoprazan-Amoxicillin Dual Therapy for Helicobacter pylori Eradication , 2022, Frontiers in Cellular and Infection Microbiology.

[2]  X. Shu,et al.  Optimization of vonoprazan‐amoxicillin dual therapy for eradicating Helicobacter pyloriinfection in China: A prospective, randomized clinical pilot study , 2022, Helicobacter.

[3]  T. Gotoda,et al.  Long term impact of vonoprazan‐based Helicobacter pylori treatment on gut microbiota and its relation to post‐treatment body weight changes , 2021, Helicobacter.

[4]  T. Gotoda,et al.  Lower impact of vonoprazan–amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication , 2021, Journal of gastroenterology and hepatology.

[5]  A. Al-Ahmad,et al.  Colonization of Helicobacter pylori in the oral cavity – an endless controversy? , 2021, Critical reviews in microbiology.

[6]  J. Jia,et al.  Helicobacter pylori infection is correlated with the incidence of erosive oral lichen planus and the alteration of the oral microbiome composition , 2021, BMC microbiology.

[7]  Kwang-Kyun Park,et al.  Oral–Gut Microbiome Axis in Gastrointestinal Disease and Cancer , 2021, Cancers.

[8]  Xiao-yu Wu,et al.  Helicobacter pylori infection is associated with the co‐occurrence of bacteria in the oral cavity and the gastric mucosa , 2021, Helicobacter.

[9]  E. El-Omar,et al.  The interplay between Helicobacter pylori and gastrointestinal microbiota , 2021, Gut microbes.

[10]  Ruiwei Shen,et al.  Changes in the human gut microbiota composition caused by Helicobacter pylori eradication therapy: A systematic review and meta‐analysis , 2020, Helicobacter.

[11]  Xuedong Zhou,et al.  Antibiotic-induced dysbiosis of the rat oral and gut microbiota and resistance to Salmonella. , 2020, Archives of oral biology.

[12]  T. Hanioka,et al.  Effects of eradication of Helicobacter pylori on oral malodor and the oral environment: a single-center observational study , 2020, BMC Research Notes.

[13]  X. Liang,et al.  Analysis of by high-throughput sequencing: Helicobacter pylori infection and salivary microbiome , 2020, BMC Oral Health.

[14]  T. Gotoda,et al.  Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan , 2020, Gut.

[15]  E. El-Omar,et al.  Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial. , 2019, The Lancet. Infectious diseases.

[16]  G. Borisy,et al.  Biogeography of the Oral Microbiome: The Site-Specialist Hypothesis. , 2019, Annual review of microbiology.

[17]  Zhenhua Zhu,et al.  The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults , 2019, Helicobacter.

[18]  William A. Walters,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[19]  Xuefeng Gao,et al.  Helicobacter pylori infection alters gastric and tongue coating microbial communities , 2019, Helicobacter.

[20]  L. Bianchi,et al.  Helicobacter pylori, transmission routes and recurrence of infection: state of the art , 2018, Acta bio-medica : Atenei Parmensis.

[21]  N. Ishimura,et al.  Oral microbiome alterations of healthy volunteers with proton pump inhibitor , 2018, Journal of gastroenterology and hepatology.

[22]  A. Hakansson,et al.  Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection. , 2018, Physiological reviews.

[23]  Abhinashi Singh Sodhi,et al.  Oral microbiome and health , 2018, AIMS microbiology.

[24]  Jun Yu,et al.  Mucosal microbiome dysbiosis in gastric carcinogenesis , 2017, Gut.

[25]  S. Ng,et al.  Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. , 2017, Gastroenterology.

[26]  P. Malfertheiner,et al.  The active bacterial assemblages of the upper GI tract in individuals with and without Helicobacter infection , 2016, Gut.

[27]  R. Hunt,et al.  Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report , 2016, Gut.

[28]  P. Malfertheiner,et al.  Kyoto global consensus report on Helicobacter pylori gastritis , 2015, Gut.

[29]  A. Nobbs,et al.  Interkingdom networking within the oral microbiome. , 2015, Microbes and infection.

[30]  Robert G. Beiko,et al.  STAMP: statistical analysis of taxonomic and functional profiles , 2014, Bioinform..

[31]  Eoin L. Brodie,et al.  Greengenes, a Chimera-Checked 16S rRNA Gene Database and Workbench Compatible with ARB , 2006, Applied and Environmental Microbiology.

[32]  R. Peek,et al.  Pathobiology of Helicobacter pylori-Induced Gastric Cancer. , 2016, Gastroenterology.